Article(id=1322125553876979944, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322125552731927464, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1628438400000, acceptedDateStr=2021-08-09, onlineDate=1793148895948, onlineDateStr=2026-10-28, pubDate=1638201600000, pubDateStr=2021-11-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793148895948, onlineIssueDateStr=2026-10-28, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793148895948, creator=13701087609, updateTime=1793148895948, updator=13701087609, issue=Issue{id=1322125552731927464, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='22', pageStart='2017', pageEnd='2120', issueExtLink='null', onlineDate='null', pubDate='1638201600000', pubDateStr='2021-11-30', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793148895675, creator='13701087609', updateTime=1793149501548, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322128094022971944, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322125552731927464, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322128094022971945, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322125552731927464, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=2017, endPage=2023, ext={EN=ArticleExt(id=1322125554057335017, articleId=1322125553876979944, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Preliminary thinking on the establishment of China's future pharmacovigilance system, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

With the increasing number of new drugs on the market, the risk of drug safety also increases. The establishment of pharmacovigilance system is proposed in the Drug Administration Law, which is of great significance to the future research and development of new drugs and drug supervision. Pharmacovigilance system includes management and technical activities. The implementation of China's pharmacovigilance system meets the requirements of new regulations and systems. This article discusses the concept and scope of the implementation of China's future pharmacovigilance system, the key points of the transformation from the adverse reaction monitoring and reporting system to the pharmacovigilance system, and the obligations and responsibilities of all parties in the pharmacovigilance system.

, authors=Ya-juan ZHANG, Hui CHEN, Yue YANG, authorsList=Ya-juan ZHANG, Hui CHEN, Yue YANG, authorCompany=null, correspAuthors=Yue YANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322125554715840746, articleId=1322125553876979944, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=面向未来的中国药物警戒制度实施的思考, columnId=1236331162679955859, journalTitle=中国新药杂志, columnName=新药述评与论坛, runingTitle=null, highlight=null, articleAbstract=

随着我国新药上市的数量和速度不断提高,上市后的药品安全风险管理更加重要。2019年新修订的《中华人民共和国药品管理法》提出建立药物警戒制度,对未来新药研发及药品监管有重要意义。药物警戒体系包括管理层面和技术层面的活动,实施中国药物警戒制度符合新法规、新制度的要求。本文将从药物警戒制度的概念和范围、不良反应监测报告制度向药物警戒制度转变的关键点、药物警戒中的各方义务与责任等方面对中国未来的药物警戒制度实施进行讨论与思考。

, authors=张雅娟, 陈慧, 杨悦, authorsList=张雅娟, 陈慧, 杨悦, authorCompany=null, correspAuthors=杨悦, authorNote=

张雅娟,女,博士,研究方向:药品监管,医院管理等。E-mail:。

, correspAuthorsNote=
杨悦,女,博士,研究员,研究方向:药品监管。E-mail:。
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=horUPZPtyuocduYghYQe9w==, magXml=hmUOw6DJAYcqjcWcRiwyhw==, pdfUrl=null, pdf=Op3dBVFP+OgVmQXAo3aPvQ==, pdfFileSize=1321554, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=qtuRfOoZVCq2Omba9s4v8g==, mapNumber=null, fund=null)}, authors=[Author(id=1322125555273683183, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhangyajuan@tsinghua.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322125555353374961, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555273683183, language=EN, stringName=Ya-juan ZHANG, firstName=Ya-juan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125555420483826, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555273683183, language=CN, stringName=张雅娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=清华大学药学院,北京 100084, bio={"content":"

张雅娟,女,博士,研究方向:药品监管,医院管理等。E-mail:。

"}, bioImg=null, bioContent=

张雅娟,女,博士,研究方向:药品监管,医院管理等。E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125555164631275, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, xref=null, ext=[AuthorCompanyExt(id=1322125555173019884, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1322125555181408493, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=清华大学药学院,北京 100084)])]), Author(id=1322125555483398388, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322125555546312950, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555483398388, language=EN, stringName=Hui CHEN, firstName=Hui, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125555609227511, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555483398388, language=CN, stringName=陈慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=清华大学药学院,北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125555164631275, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, xref=null, ext=[AuthorCompanyExt(id=1322125555173019884, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1322125555181408493, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=清华大学药学院,北京 100084)])]), Author(id=1322125555697307897, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=yanghappy@tsinghua.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322125555785388283, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555697307897, language=EN, stringName=Yue YANG, firstName=Yue, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125555856691452, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555697307897, language=CN, stringName=杨悦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=清华大学药学院,北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125555164631275, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, xref=null, ext=[AuthorCompanyExt(id=1322125555173019884, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1322125555181408493, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=清华大学药学院,北京 100084)])])], keywords=[Keyword(id=1322125555944771837, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, language=EN, orderNo=1, keyword=pharmacovigilance system), Keyword(id=1322125556024463614, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, language=EN, orderNo=2, keyword=risk control), Keyword(id=1322125556095766783, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, language=EN, orderNo=3, keyword=signal recognition), Keyword(id=1322125556162875648, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, language=CN, orderNo=1, keyword=药物警戒), Keyword(id=1322125556259344641, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, language=CN, orderNo=2, keyword=风险控制), Keyword(id=1322125556330647810, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, language=CN, orderNo=3, keyword=信号识别)], refs=[Reference(id=1322125556666192133, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=杨悦. 我国药物警戒制度实施与ICH药物警戒指导原则转化适用[J]. 中国药物警戒, 2020, 17(2): 65-71., articleTitle=null, refAbstract=null), Reference(id=1322125556750078214, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=彭丽丽, 王丹, 沈璐, 等. 药物警戒的起源与发展[J]. 中国药物警戒, 2016, 13(7): 410-413., articleTitle=null, refAbstract=null), Reference(id=1322125556817187079, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO. The importance of pharmacovigilance (safety monitoring of medicinal products)[M]. Geneva: Word Health Organization, Collaborating Centre for International Drug Monitoring, 2002: 1-8., articleTitle=null, refAbstract=null), Reference(id=1322125556884295944, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品评价中心. 上市后安全数据管理: 快速报告的定义和标准(E2D)[EB/OL]. (2019-09-27). http://www.cdr-adr.org.cn/drug_1/ICHzd_1/ICH_E2D/201909/t20190927_36891.html., articleTitle=null, refAbstract=null), Reference(id=1322125556976570633, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=中华人民共和国卫生部. 《药品不良反应报告和监测管理办法》(卫生部令第81号)[EB/OL]. (2011-05-24). http://www.gov.cn/flfg/2011-05/24/content_1870110.html., articleTitle=null, refAbstract=null), Reference(id=1322125557052068106, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Council for International Organizations of Medical Sciences. Practical aspects of signal detection in pharmacovigilance: report of CIOMS Working Group Ⅷ[M]. Geneva: Council for International Organizations of Medical Sciences, 2010: 6-7., articleTitle=null, refAbstract=null), Reference(id=1322125557194674443, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH E2D guideline: post-approval safety data management: definitions and standards for expedited reporting[EB/OL]. (2003-11-12) [2020-06-23]. https://database.ich.org/sites/default/files/E2D_Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1322125557282754828, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=施雯慧, 巴磊, 周健, 等. 欧盟、美国和日本的药物警戒信号管理体系比较研究[J]. 中国药房, 2021, 32(4): 406-412., articleTitle=null, refAbstract=null), Reference(id=1322125557370835213, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品评价中心. 定期获益-风险评估报告(PBRER)E2C(R2)[EB/OL]. [2020-07-22]. http://www.cdr-adr.org.cn/tzgg_home/202007/t20200722_47625.html., articleTitle=null, refAbstract=null), Reference(id=1322125557446332686, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=PHILLIP FP. 风险管理计划[J]. 中国药物警戒, 2009, 16(11): 695-697., articleTitle=null, refAbstract=null), Reference(id=1322125557509247247, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=杨志敏. 药品说明书的规范性与风险控制——以新型抗肿瘤药为例[J]. 中国食品药品监管, 2019(11): 40-47., articleTitle=null, refAbstract=null), Reference(id=1322125557597327632, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=于金冉, 王宏伟, 王艺芳, 等. 美国药品标识全生命周期管理研究与启示[J]. 中国药物警戒, 2018, 15(6): 333-338., articleTitle=null, refAbstract=null), Reference(id=1322125557664436497, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=邹丽敏, 齐玥丽, 唐凌, 等. 如何撰写符合E2E指导原则的新药上市后风险管理计划[J]. 中国药物警戒, 2020, 17(11): 780-784., articleTitle=null, refAbstract=null), Reference(id=1322125557739933970, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=袁林, 高燕, 路长飞. 我国建立药物警戒制度的初步思考[J]. 中国药物警戒, 2020, 17(11): 749-752., articleTitle=null, refAbstract=null), Reference(id=1322125557819625747, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Center for Drug Evaluation of National Medical Products Administration. Requirements on format and content of the risk management plan for anti-tumor drugs application[EB/OL]. (2018-09-13) [2019-11-04]. http://www.cde.org.cn/dzkw.do?method=largePage&id=314680., articleTitle=null, refAbstract=null), Reference(id=1322125557886734612, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=王涛. 美国药物警戒体系浅析及对我国的启示[J]. 医药导报, 2017, 36(4): 361-365., articleTitle=null, refAbstract=null), Reference(id=1322125557962232085, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH Guideline. E2D: ICH Harmonised Tripartite Guideline. Post-approval safety data management: definitions and standards for expedited reporting E2D[EB/OL]. (2016-03-29). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2D/Step4/E2D_Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1322125558041923862, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=MITCHELL AA, VAN BENNEKOM CM, LOUIK C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin[J]. Engl J Med, 1995, 333(2): 101-106., articleTitle=null, refAbstract=null), Reference(id=1322125558121615639, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=宋春艳, 王小宁, 辛蕾. 创新药品监管方式打造智慧监管新格局[J]. 中国食品药品监管, 2020(3): 54-59., articleTitle=null, refAbstract=null), Reference(id=1322125558201307416, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=冯亚楠, 刘欣欣, 李永辉, 等. 新《药品管理法》下医疗机构药物警戒工作面临的挑战[J]. 中国药物警戒, 2020, 17(9): 572-582., articleTitle=null, refAbstract=null), Reference(id=1322125558268416281, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=National Medical Products Administration. Announcement of national medical products administration on the direct reporting of adverse reactions by marketing authorization holder (No.66 of 2018)[EB/OL]. (2018-09-30) [2020-03-25]. http://www.nmpa.gov.cn/WS04/CL2093/331214.html., articleTitle=null, refAbstract=null), Reference(id=1322125558339719450, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=杨悦. 现阶段药品监管的三大挑战[N]. 医药经济报, 2017-08-14(3)., articleTitle=null, refAbstract=null), Reference(id=1322125558436188443, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=原国家食品药品监督管理总局南方医药经济研究所. 2016年儿童用药安全调查报告白皮书[R]. 2016., articleTitle=null, refAbstract=null), Reference(id=1322125558507491612, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=沈璐, 刘巍, 郭雪, 等. 我国药品不良反应监测模式的趋势探析[J]. 中国药物警戒, 2017, 14(5): 295-308, articleTitle=null, refAbstract=null), Reference(id=1322125558591377693, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=孙巍巍, 王扬, 何乐毅凡, 等. 我国药物警戒的研究现状与发展[C]//第二届临床中药学大会论文集.2018: 3., articleTitle=null, refAbstract=null), Reference(id=1322125558666875166, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=全国人民代表大会常务委员会. 中华人民共和国药品管理法[EB/OL]. (2019-08-27) [2020-06-23]. http://www.nmpa.gov.cn/WS04/CL2076/357712.html., articleTitle=null, refAbstract=null), Reference(id=1322125558738178335, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局. 国家药品监督管理局关于药品上市许可持有人直接报告不良反应事宜的公告: 2018年第66号[EB/OL]. (2018-09-29) [2020-06-23]. http://www.nmpa.gov.cn/WS04/CL2093/331214.html., articleTitle=null, refAbstract=null), Reference(id=1322125558826258720, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=柳鹏程, 陈锦敏, 孙祯辉, 等. 浅析ICH E2指导原则中MAA/MAH药物警戒职责及其启示[J]. 中国医药工业杂志, 2020, 51(2): 290-296, 304., articleTitle=null, refAbstract=null), Reference(id=1322125558897561889, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=黄仟, 温泽淮. 倡议建立协调统一的药物不良反应因果关系评价标准[J]. 中国新药杂志, 2021, 30(12): 1132-1136., articleTitle=null, refAbstract=null), Reference(id=1322125558985642274, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=张琪, 颜建周, 姚雯, 等. 欧盟药品上市后安全性研究制度及对我国的启示[J]. 中国新药杂志, 2020, 29(1): 9-14., articleTitle=null, refAbstract=null)], funds=[Fund(id=1322125556435505411, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, awardId=20202001532, language=CN, fundingSource=国家药品监督管理局典型国家药物警戒体系研究(20202001532), fundOrder=null, country=null), Fund(id=1322125556527780100, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, awardId=20202001623, language=CN, fundingSource=国家药品监督管理局国际创新药上市后药物警戒监管法律法规及方式方法研究(20202001623), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1322125555164631275, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, xref=null, ext=[AuthorCompanyExt(id=1322125555173019884, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1322125555181408493, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=清华大学药学院,北京 100084)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I22/2017, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I22/2017, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I22/2017, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I22/2017, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1638201600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
面向未来的中国药物警戒制度实施的思考
收藏切换
PDF下载
张雅娟 , 陈慧 , 杨悦
中国新药杂志 | 新药述评与论坛 2021,30(22): 2017-2023
收起
收藏切换
中国新药杂志 |新药述评与论坛 2021 , 30 (22) : 2017 -2023
面向未来的中国药物警戒制度实施的思考
全屏
[Author(id=1322125555273683183, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhangyajuan@tsinghua.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322125555353374961, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555273683183, language=EN, stringName=Ya-juan ZHANG, firstName=Ya-juan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125555420483826, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555273683183, language=CN, stringName=张雅娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=清华大学药学院,北京 100084, bio={"content":"

张雅娟,女,博士,研究方向:药品监管,医院管理等。E-mail:。

"}, bioImg=null, bioContent=

张雅娟,女,博士,研究方向:药品监管,医院管理等。E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125555164631275, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, xref=null, ext=[AuthorCompanyExt(id=1322125555173019884, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1322125555181408493, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=清华大学药学院,北京 100084)])]), Author(id=1322125555483398388, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322125555546312950, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555483398388, language=EN, stringName=Hui CHEN, firstName=Hui, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125555609227511, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555483398388, language=CN, stringName=陈慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=清华大学药学院,北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125555164631275, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, xref=null, ext=[AuthorCompanyExt(id=1322125555173019884, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1322125555181408493, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=清华大学药学院,北京 100084)])]), Author(id=1322125555697307897, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=yanghappy@tsinghua.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322125555785388283, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555697307897, language=EN, stringName=Yue YANG, firstName=Yue, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322125555856691452, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, authorId=1322125555697307897, language=CN, stringName=杨悦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=清华大学药学院,北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322125555164631275, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, xref=null, ext=[AuthorCompanyExt(id=1322125555173019884, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1322125555181408493, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322125553876979944, companyId=1322125555164631275, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=清华大学药学院,北京 100084)])])]
张雅娟 , 陈慧, 杨悦
作者信息
  • 清华大学药学院,北京 100084
通讯作者:
杨悦,女,博士,研究员,研究方向:药品监管。E-mail:。
作者简介:

张雅娟,女,博士,研究方向:药品监管,医院管理等。E-mail:。

Preliminary thinking on the establishment of China's future pharmacovigilance system
Ya-juan ZHANG , Hui CHEN, Yue YANG
Affiliations
  • School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China
出版时间: 2021-11-30
文章导航
收藏切换

随着我国新药上市的数量和速度不断提高,上市后的药品安全风险管理更加重要。2019年新修订的《中华人民共和国药品管理法》提出建立药物警戒制度,对未来新药研发及药品监管有重要意义。药物警戒体系包括管理层面和技术层面的活动,实施中国药物警戒制度符合新法规、新制度的要求。本文将从药物警戒制度的概念和范围、不良反应监测报告制度向药物警戒制度转变的关键点、药物警戒中的各方义务与责任等方面对中国未来的药物警戒制度实施进行讨论与思考。

药物警戒  /  风险控制  /  信号识别

With the increasing number of new drugs on the market, the risk of drug safety also increases. The establishment of pharmacovigilance system is proposed in the Drug Administration Law, which is of great significance to the future research and development of new drugs and drug supervision. Pharmacovigilance system includes management and technical activities. The implementation of China's pharmacovigilance system meets the requirements of new regulations and systems. This article discusses the concept and scope of the implementation of China's future pharmacovigilance system, the key points of the transformation from the adverse reaction monitoring and reporting system to the pharmacovigilance system, and the obligations and responsibilities of all parties in the pharmacovigilance system.

pharmacovigilance system  /  risk control  /  signal recognition
张雅娟, 陈慧, 杨悦. 面向未来的中国药物警戒制度实施的思考. 中国新药杂志, 2021 , 30 (22) : 2017 -2023 .
Ya-juan ZHANG, Hui CHEN, Yue YANG. Preliminary thinking on the establishment of China's future pharmacovigilance system[J]. Chinese Journal of New Drugs, 2021 , 30 (22) : 2017 -2023 .
  • 国家药品监督管理局典型国家药物警戒体系研究(20202001532)
  • 国家药品监督管理局国际创新药上市后药物警戒监管法律法规及方式方法研究(20202001623)
参考文献 引证文献
排序方式:
[1]
杨悦. 我国药物警戒制度实施与ICH药物警戒指导原则转化适用[J]. 中国药物警戒, 2020, 17(2): 65-71.
[2]
彭丽丽, 王丹, 沈璐, 等. 药物警戒的起源与发展[J]. 中国药物警戒, 2016, 13(7): 410-413.
[3]
WHO. The importance of pharmacovigilance (safety monitoring of medicinal products)[M]. Geneva: Word Health Organization, Collaborating Centre for International Drug Monitoring, 2002: 1-8.
[4]
国家药品监督管理局药品评价中心. 上市后安全数据管理: 快速报告的定义和标准(E2D)[EB/OL]. (2019-09-27). http://www.cdr-adr.org.cn/drug_1/ICHzd_1/ICH_E2D/201909/t20190927_36891.html.
[5]
中华人民共和国卫生部. 《药品不良反应报告和监测管理办法》(卫生部令第81号)[EB/OL]. (2011-05-24). http://www.gov.cn/flfg/2011-05/24/content_1870110.html.
[6]
Council for International Organizations of Medical Sciences. Practical aspects of signal detection in pharmacovigilance: report of CIOMS Working Group Ⅷ[M]. Geneva: Council for International Organizations of Medical Sciences, 2010: 6-7.
[7]
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH E2D guideline: post-approval safety data management: definitions and standards for expedited reporting[EB/OL]. (2003-11-12) [2020-06-23]. https://database.ich.org/sites/default/files/E2D_Guideline.pdf.
[8]
施雯慧, 巴磊, 周健, 等. 欧盟、美国和日本的药物警戒信号管理体系比较研究[J]. 中国药房, 2021, 32(4): 406-412.
[9]
国家药品监督管理局药品评价中心. 定期获益-风险评估报告(PBRER)E2C(R2)[EB/OL]. [2020-07-22]. http://www.cdr-adr.org.cn/tzgg_home/202007/t20200722_47625.html.
[10]
PHILLIP FP. 风险管理计划[J]. 中国药物警戒, 2009, 16(11): 695-697.
[11]
杨志敏. 药品说明书的规范性与风险控制——以新型抗肿瘤药为例[J]. 中国食品药品监管, 2019(11): 40-47.
[12]
于金冉, 王宏伟, 王艺芳, 等. 美国药品标识全生命周期管理研究与启示[J]. 中国药物警戒, 2018, 15(6): 333-338.
[13]
邹丽敏, 齐玥丽, 唐凌, 等. 如何撰写符合E2E指导原则的新药上市后风险管理计划[J]. 中国药物警戒, 2020, 17(11): 780-784.
[14]
袁林, 高燕, 路长飞. 我国建立药物警戒制度的初步思考[J]. 中国药物警戒, 2020, 17(11): 749-752.
[15]
Center for Drug Evaluation of National Medical Products Administration. Requirements on format and content of the risk management plan for anti-tumor drugs application[EB/OL]. (2018-09-13) [2019-11-04]. http://www.cde.org.cn/dzkw.do?method=largePage&id=314680.
[16]
王涛. 美国药物警戒体系浅析及对我国的启示[J]. 医药导报, 2017, 36(4): 361-365.
[17]
ICH Guideline. E2D: ICH Harmonised Tripartite Guideline. Post-approval safety data management: definitions and standards for expedited reporting E2D[EB/OL]. (2016-03-29). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2D/Step4/E2D_Guideline.pdf.
[18]
MITCHELL AA, VAN BENNEKOM CM, LOUIK C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin[J]. Engl J Med, 1995, 333(2): 101-106.
[19]
宋春艳, 王小宁, 辛蕾. 创新药品监管方式打造智慧监管新格局[J]. 中国食品药品监管, 2020(3): 54-59.
[20]
冯亚楠, 刘欣欣, 李永辉, 等. 新《药品管理法》下医疗机构药物警戒工作面临的挑战[J]. 中国药物警戒, 2020, 17(9): 572-582.
[21]
National Medical Products Administration. Announcement of national medical products administration on the direct reporting of adverse reactions by marketing authorization holder (No.66 of 2018)[EB/OL]. (2018-09-30) [2020-03-25]. http://www.nmpa.gov.cn/WS04/CL2093/331214.html.
[22]
杨悦. 现阶段药品监管的三大挑战[N]. 医药经济报, 2017-08-14(3).
[23]
原国家食品药品监督管理总局南方医药经济研究所. 2016年儿童用药安全调查报告白皮书[R]. 2016.
[24]
沈璐, 刘巍, 郭雪, 等. 我国药品不良反应监测模式的趋势探析[J]. 中国药物警戒, 2017, 14(5): 295-308
[25]
孙巍巍, 王扬, 何乐毅凡, 等. 我国药物警戒的研究现状与发展[C]//第二届临床中药学大会论文集.2018: 3.
[26]
全国人民代表大会常务委员会. 中华人民共和国药品管理法[EB/OL]. (2019-08-27) [2020-06-23]. http://www.nmpa.gov.cn/WS04/CL2076/357712.html.
[27]
国家药品监督管理局. 国家药品监督管理局关于药品上市许可持有人直接报告不良反应事宜的公告: 2018年第66号[EB/OL]. (2018-09-29) [2020-06-23]. http://www.nmpa.gov.cn/WS04/CL2093/331214.html.
[28]
柳鹏程, 陈锦敏, 孙祯辉, 等. 浅析ICH E2指导原则中MAA/MAH药物警戒职责及其启示[J]. 中国医药工业杂志, 2020, 51(2): 290-296, 304.
[29]
黄仟, 温泽淮. 倡议建立协调统一的药物不良反应因果关系评价标准[J]. 中国新药杂志, 2021, 30(12): 1132-1136.
[30]
张琪, 颜建周, 姚雯, 等. 欧盟药品上市后安全性研究制度及对我国的启示[J]. 中国新药杂志, 2020, 29(1): 9-14.
2021年第30卷第22期
PDF下载
16
2
引用本文
BibTeX
文章信息
  • 首发时间:2026-10-28
  • 出版时间:2021-11-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2021-08-09
基金
国家药品监督管理局典型国家药物警戒体系研究(20202001532)
国家药品监督管理局国际创新药上市后药物警戒监管法律法规及方式方法研究(20202001623)
作者信息
    清华大学药学院,北京 100084

通讯作者:

杨悦,女,博士,研究员,研究方向:药品监管。E-mail:。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322125553876979944
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏